Microsoft and Apple distanced themselves from OpenAI | China struggled after the release of its inflation data |
Finimize

TOGETHER WITH

Hi John, here's what you need to know for July 11th in 3:14 minutes.

👀 We asked, you answered. Sneak a peek at our latest Modern Investor Pulse report, and discover how your fellow investors are investing this quarter. Read it here

Today's big stories

  1. Microsoft and Apple put space between themselves and OpenAI, after feeling the heat from regulators
  2. Three signs to watch for, if you’re looking for a “safe” bitcoin moment – Read Now
  3. China inched closer to deflation, a worrying sign for the world's second-biggest economy

Stood Up

Stood Up

What’s going on here?

Microsoft hopped out of its OpenAI board seat “effective immediately”, according to the firm’s letter out on Tuesday.

What does this mean?

Microsoft’s party line is that its observer seat – which lets the holder chime in on discussions but not vote, essentially a gossiper’s dream – is no longer needed, as OpenAI has cleaned up its act since last year’s boardroom fallout. Apple has also stepped away, despite previously planning to pin its name on one of the startup’s spinning office chairs. But this distance might have something to do with the heat coming from both European and US regulators. They’re concerned that Big Tech companies are wielding too much power, especially in the potentially world-changing AI sector. Mind you, Microsoft has hardly cut the cord: the firm’s $13 billion investment in OpenAI entitles it to a chunk of profit for some time, and it’s still making bank from the startup’s reliance on its Azure computing services.

Why should I care?

Zooming out: Magic act.

TSMC briefly joined its fellow AI explorers in the exclusive trillion-dollar club this week. As the sole supplier of advanced AI chips for Nvidia and Apple, the Taiwanese chipmaker has investors under its spell – and that’s not likely to change anytime soon. TSMC announced on Wednesday that last quarter’s sales were a better-than-expected 40% higher than the same time a year ago.

The bigger picture: Money’s no object… yet.

Big Tech companies are spending whatever they need to secure chips, data centers, and innovative technology in the pursuit of super-smart systems. But maybe they should watch the budget: skeptics doubt that AI will be all it’s cracked up to be, and Big Tech has gambled on anticlimactic technologies before. (You’ll notice you’re not driving an Apple car or working from the metaverse yet.) Apple might have the right strategy, then, partnering up with OpenAI instead of spending billions to develop its own systems.

Copy to share story: https://app.finimize.com/content/stood-up

🙋 Ask a question

Analyst Take

Three Signals To Gauge Whether It’s “Safe” To Buy The Bitcoin Dip

Three Signals To Gauge Whether It’s “Safe” To Buy The Bitcoin Dip

By Jonathan Hobbs, CFA, Analyst

What’s Going On Here?

Bitcoin dropped 27% between March 14th and July 6th, the biggest fall since it bottomed near $15,000 a coin back in November of 2022.

If you track its week-to-week price moves, you’ll see the crypto kingpin is now in a downtrend for the first time since then – making lower lows and lower highs.

And, sure, you can YOLO into bitcoin now and things could work out great. But what if this dip keeps… dipping?

If you’re the more cautious crypto type, you might want to see one or more safety signals before buying in.

That’s today’s Insight: three signs to watch for, if you’re looking for a “safe” bitcoin moment.

Read or listen to the Insight here

SPONSORED BY BIOSTEM

Medical tech that help millions – and make millions doing it

Biostem (BSEM) is on a mission to improve millions of lives by rethinking the way we heal wounds.

The company’s products are designed to help the healing process of surgical patients who have undergone major procedures and diabetic patients who suffer from nasty wounds.

That’s a lot of people: the market for diabetic foot ulcers alone was big enough to be worth over $4 billion in 2021. And now, regenerative healing is becoming a reality.

BSEM’s allografts helped bring in $41.9 million of revenue last quarter, nearly 71 times higher than a year ago. No wonder Zacks Small Cap Research increased BSEM’s stock price estimate to $22.

BSEM partnered up with McCoy Clinical Consulting last quarter, too. The firm will lead trials on ulcer products for vein conditions and diabetes complications, to optimize the trial and development stage.

If you want to find out more about the company bringing futuristic wound care into today’s medical field, take a deeper look at BSEM’s numbers.

Find Out More

This content is for US investors only, if you are not a US investor please ignore this content. This content is a paid advertisement for BioStem (OTC:BSEM) from Sideways Frequency and Finimize. This is not Finimize editorial content. Finimize received a fixed fee for producing, hosting and promoting this content on behalf of BioStem (OTC:BSEM), totalling $10,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Sideways Frequency or BioStem (OTC:BSEM). Finimize and its principals have no ownership in BioStem (OTC:BSEM). The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results.

When you support our sponsors, you support us. Thanks for that.

If you want your brand featured here, get in touch.

Shrinking Violet

Shrinking Violet

What’s going on here?

China released disappointing inflation data for June on Wednesday, and the numbers suggest the world’s second-biggest economy could use a pep talk.

What does this mean?

While most major economies are contending with inflation, China is nearing deflationary territory. Consumer prices were 0.2% higher in June than the same time a year ago, less than the 0.4% expected. The core consumer price index, which strips out volatile food and energy prices, wasn’t much different. It rose just 0.6% compared to last June – the same tiny increase that China reported in May. Prices of products straight from the factory have been on the slide since 2022, too. Now, against the backdrop of bigger bills every time you pick up milk, falling prices might sound like a relief. But deflation is a real stumbling block, indicating that folk aren’t spending enough to keep the economy moving. And unless China can bolster its struggling real estate market, which is shaking folks’ financial confidence, purse strings are unlikely to loosen anytime soon.

Why should I care?

Zooming out: Double trouble.

China’s fortunes now rest on the export industry. It’s bad timing, then, that the country’s being stamped with trade tariffs left, right, and center. China has a glut of EVs that it wants to shift to the US and Europe, at government-subsidized prices that the likes of Tesla can’t compete with. The US has already brought in a 100% tax on Chinese EVs, while Europe has fees up to 38%.

The bigger picture: More arguments than a university debate club.

China isn’t taking tariffs lying down. The country’s opened an investigation into European Union trade barriers, questioning whether the new tariffs are an illegal barrier to free trade. Along with cars, China’s looking into sectors like rail, solar, and wind power – all of which Europe is trying to protect from Chinese competition. No wonder China is stuck on many investors’ “avoid” lists.

Copy to share story: https://app.finimize.com/content/shrinking-violet

🙋 Ask a question

💬 Quote of the day

"The more I paint the more I like everything."

– Jean-Michel Basquiat (an American artist)
Tweet this

Private investments are becoming a little more public

Oakley Capital established itself as a name to know in the private equity world at last year’s Modern Investor Summit.

The publicly listed company funds early-stage ventures, offering investors a chance to benefit from private equity – an opportunity often reserved for institutional traders and uber-wealthy individuals.

By taking to our Modern Investor Summit stage last December, Oakley detailed the benefits of private investments, as well as how to diversify, spot headwinds, and find market disruptors.

Oakley’s shares have risen 150% in the last five years, so its tips and tricks are well worth listening to: you can catch up on last year’s session on YouTube for free.

And if you want to put your brand in the spotlight this year, drop us a line to talk about speaker slots and promotional packages.

Talk To Us

🎯 On Our Radar

1. Taking a toll. What effect does space travel have on the human body.

2. There's nothing like staying active. Here's how different active investing strategies could play out for you.*

3. Berry good. The secret history of summer's favorite fruit, the strawberry.

4. Gyms, restaurants, car dealerships. Celebrities and the ultra-wealthy have been investing in franchises for years, and now you can too.*

5. Golden ticket. Imagine if we had a memo that could give us that vital life lessons ahead of time.

When you support our sponsors, you support us. Thanks for that.

🌍 Finimize Live

🤩 Grab your tickets...

All events in UK time.
💃🏼 Finimize Ladies Investing Club: 6.30pm, July 18th
🤫 Secret Strategies Of A Long-Term Investor: 5pm, July 24th
💰How To Invest Like A Modern Warren Buffett: 5pm, Aug 14th
🔨 Five Portfolio Hacks For Busy Investors: 5pm, Sept 12th
🚀 2024 Modern Investor Summit: 2pm, December 3rd

❤️ Share with a friend

Thanks for reading John. If you liked today's brief, we'd love for you to share it with a friend.

You stay classy, John 😉

We’d love to hear your thoughts. Give feedback

Want to advertise with us too? Get in touch

Image Credits:

Image credits: Dall-e | Dall-e

Preferences:

Update your email or change preferences

View in browser

Unsubscribe from all Finimize Emails

😴

Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2021

View Online